15.12 09:32 | dpa-AFX: Original-Research: HAEMATO AG (von GBC AG): ausgesetzt |
15.12 09:32 | dpa-AFX: Original-Research: HAEMATO AG (von GBC AG): ausgesetzt |
15.12 09:32 | Original-Research: HAEMATO AG (von GBC AG): ausgesetzt |
15.12 09:32 | Original-Research: HAEMATO AG (von GBC AG): ausgesetzt |
15.12 09:31 | dpa-AFX: Original-Research: HAEMATO AG (von GBC AG): suspended |
15.12 09:31 | dpa-AFX: Original-Research: HAEMATO AG (von GBC AG): suspended |
15.12 09:31 | Original-Research: HAEMATO AG (von GBC AG): suspended |
15.12 09:31 | Original-Research: HAEMATO AG (von GBC AG): suspended |
13.12 10:01 | Original-Research: Haemato AG (von First Berlin Equity Research GmbH): Not Rated |
13.12 10:01 | dpa-AFX: Original-Research: Haemato AG (von First Berlin Equity Research GmbH): Not Rated |
13.12 10:01 | dpa-AFX: Original-Research: Haemato AG (von First Berlin Equity Research GmbH): Not Rated |
13.12 10:01 | Original-Research: Haemato AG (von First Berlin Equity Research GmbH): Not Rated |
30.11 14:15 | EQS-Adhoc: HAEMATO AG: Kündigung Einbeziehung Freiverkehr |
30.11 14:15 | dpa-AFX: EQS-Adhoc: HAEMATO AG: Kündigung Einbeziehung Freiverkehr (deutsch) |
30.11 14:15 | dpa-AFX: EQS-Adhoc: HAEMATO AG: Termination of listing in the Open Market (english) |
30.11 14:15 | dpa-AFX: EQS-Adhoc: HAEMATO AG: Termination of listing in the Open Market (english) |
30.11 14:15 | EQS-Adhoc: HAEMATO AG: Kündigung Einbeziehung Freiverkehr (deutsch) |
30.11 14:14 | EQS-Adhoc: HAEMATO AG: Termination of listing in the Open Market |
16.11 08:21 | dpa-AFX: EQS-News: HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in (english) |
16.11 08:21 | dpa-AFX: EQS-News: HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in (english) |
|